Investment in securities market are subject to market risks. Read all the related documents carefully before investing
Revealed
Our Big Prediction
**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Pharma
Stocks 
Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results. Also check out Equitymaster's powerful stock screener to find the top pharma companies in India.
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| AARTI DRUGS | 428.35 -1.95% | 428.50 -1.95% |
|
More Info
|
| AJANTA PHARMA | 3,539.95 0.66% | 3,533.40 0.38% |
|
More Info
|
| ALEMBIC PHARMA | 812.15 -0.58% | 810.95 -0.67% |
|
More Info
|
| AUROBINDO PHARMA | 1,675.45 0.39% | 1,679.80 0.68% |
|
More Info
|
| BIOCON | 390.95 0.24% | 390.65 -0.26% |
|
More Info
|
| CIPLA | 1,365.00 -1.09% | 1,366.00 -0.53% |
|
More Info
|
| DIVIS LABORATORIES | 9,326.00 -0.84% | 9,322.00 -1.23% |
|
More Info
|
| DR. REDDYS LAB | 1,161.00 1.77% | 1,165.50 1.97% |
|
More Info
|
| GLENMARK PHARMA | 2,416.90 0.00% | 2,419.20 0.17% |
|
More Info
|
| INDOCO REMEDIES | 263.30 3.64% | 263.02 3.45% |
|
More Info
|
| IPCA LABS | 1,969.50 -0.03% | 1,968.50 -0.12% |
|
More Info
|
| J.B.CHEMICALS | 2,412.25 -3.73% | 2,408.90 -3.87% |
|
More Info
|
| LUPIN | 2,096.00 1.01% | 2,095.00 0.83% |
|
More Info
|
| MANKIND PHARMA | 2,277.00 1.38% | 2,280.00 1.86% |
|
More Info
|
| NATCO PHARMA | 815.10 -0.48% | 815.35 -0.40% |
|
More Info
|
| NIFTY 50 | Not Listed | 23,398.10 -0.34% |
|
More Info
|
| ORCHID PHARMA | 1,003.85 -1.12% | 1,003.05 -1.28% |
|
More Info
|
| PANACEA BIOTECH | 398.05 2.50% | 397.65 2.32% |
|
More Info
|
| S&P BSE HEALTHCARE | 51,238.13 -0.18% | Not Listed |
|
More Info
|
| S&P BSE SENSEX | 74,781.76 -0.16% | Not Listed |
|
More Info
|
| STRIDES PHARMA SCIENCE | 1,186.10 -2.59% | 1,183.40 -2.76% |
|
More Info
|
| SUDEEP PHARMA LTD. | 1,200.60 -0.96% | 1,202.80 -0.88% |
|
More Info
|
| SUN PHARMA | 1,842.00 -1.18% | 1,840.00 -1.13% |
|
More Info
|
| TORRENT PHARMA | 4,975.00 0.95% | 4,965.50 0.72% |
|
More Info
|
| WOCKHARDT | 2,181.15 -1.75% | 2,179.40 -1.86% |
|
More Info
|
| ZYDUS LIFESCIENCES | 1,119.50 0.13% | 1,121.00 0.29% |
|
More Info
|
BSE prices: September 11, 2026 (Close) NSE prices: September 11, 2026 (Close)
Indian Pharma Stocks Update
The NIFTY PHARMA Index was at 26,532.4 (down 0.1%). The index is down 0.8% over the last 30 days. And over the last 1 year, it has gained 19.4%.
Within the Indian Pharma sector, the top gainers were INDOCO REMEDIES (up 3.6%) and PANACEA BIOTECH (up 2.5%). On the other hand, STRIDES PHARMA SCIENCE (down 2.6%) and AARTI DRUGS (down 2.0%) were among the top losers.
Meanwhile, the benchmark NIFTY 50 was at 23,398.1 (down 0.3%).
FAQs
Which are the top Indian pharma companies in India?
Based on marketcap, these are the top pharma companies in India:
You can see the full list of pharmaceuticals stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster’s Indian stock screener which has a separate screen for top pharma companies in India .
What are the top gainers and top losers within the Indian pharma sector today?
Within the Indian Pharma sector, the top gainers were INDOCO REMEDIES (up 3.6%) and PANACEA BIOTECH (up 2.5%). On the other hand, J.B.CHEMICALS (down 3.7%) and STRIDES PHARMA SCIENCE (down 2.6%) were among the top losers.
For more, please check out our pharma sector report.
How should you value Indian pharma companies?
Investing in stocks requires careful analysis of financial data to find out a company's true worth. However, an easier way to find out about a company's performance is to look at its financial ratios.
Two commonly used financial ratios used in the valuation of stocks are -
Price to Earnings Ratio (P/E) - It compares the company's stock price with its earnings per share. The higher the P/E ratio, the more expensive the stock.
Price to Book Value Ratio (P/BV) - It compares a firm's market capitalization to its book value. A high P/BV indicates markets believe the company's assets to be undervalued and vice versa.
To know more about the healthcare sector's past and ongoing performance, have a look at the performance of the BSE Healthcare Index.
Which are some important indices one should track?
Well, it depends on what your goals are.
Having said that, the two key indices to track are the BSE Sensex which contains the list of BSE 30 stocks and the NSE Nifty which contains the list of NSE 50 stocks.
However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.
For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.
Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.
Which important sectoral indices should one track?
It depends on one's specific interests and investment goals.
Some popular sectoral indices to track in addition to the broader market indices are BSE IT index, BSE realty index, BSE manufacturing index and BSE auto index.
It's important to research and understand the industries and companies included in each sectoral index to make informed investment decisions.
Today's Market
![]()
Sensex Today Ends 121 Points Lower | Nifty Below 23,400 | Cochin Shipyard Down 9%(Closing)
Sensex Today Ends 121 Points Lower | Nifty Below 23,400 | Cochin Shipyard Down 9%Although the benchmark indices opened lower, they traded positive throughout the session and ultimately closed green.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
- Hidden Treasure
- Forever Stocks
- Big Wave Profits
- Equitymaster Venture
- Microcap Millionaires
- Momentum Profits
- Double Income
- Midcap Value Alert
- Exponential Profits
- Annual Breakout Alert
- Lazy Millionaire
- Phase One Alert
- InsiderPro Stocks
- StockSelect
- Private Briefing
- Active Wealth Multiplier 2030
- FundSelect
- Fund Advantage
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
- Best Defence Stocks in India
- Upcoming Dividend Stocks
- Best Semiconductor Stocks in India
- Data Center Stocks in India
- Best Railway Stocks in India
- Best Solar Stocks in India
- Fastest Growing Stocks in India
- List of BSE Sensex 30 Stocks
- Adani Group Shares
- Stocks Recently Bought by FIIs in India
- Top Value Stocks in India
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, enlistment with BSE as IA and RA, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing any content from this website whether wholly or in part, for any purpose without the permission of Quantum Information Services Private Limited is strictly prohibited and shall be deemed to be copyright infringement.
Quantum Information Services Private Limited (QIS) is a SEBI registered Research Analyst (bearing registration no INH000021128) and Investment Adviser(Reg. No: INA000000680). Consequent upon the merger of Equitymaster Research Private Limited into QIS, effective October 30, 2025 QIS owns and operates brand 'Equitymaster' and website www.equitymaster.com. This does not constitute or is not intended to constitute an offer to buy or sell, or a solicitation to an offer to buy or sell financial products, units or securities and QIS including its employees, personnel, directors, associates will not be liable for any losses (direct or indirect) incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. All content and information is provided on an 'As Is' basis by QIS. Information herein is believed to be reliable but QIS does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. The services rendered by QIS are on a best effort basis. QIS does not assure or guarantee the user any minimum or fixed returns. The securities quoted, if any are for illustration only and are not recommendatory. Use of this information is at the user's own risk. The user must make his own investment decisions based on his specific investment objective and financial position and using such independent advisors as he believes necessary. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject QIS or its affiliates to any registration or licensing requirement.
The performance data quoted represents past performance and does not guarantee future results. As a condition to accessing QIS's content and website, you agree to our Terms and Conditions of Use, available here.